rHEALTH Technology Issued New Patent For Vital Sign Instrument Design
CAMBRIDGE, Mass., March 27, 2018 – rHEALTH LLC announced the issuance of a new U.S. design patent for an instrument filed by DNA Medicine Institute (DMI). This innovative design enhances the diverse measurement capabilities of the rHEALTH digital health platform, representing significant advances in point-of-care testing technologies.
The U.S. Patent and Trademark Office has granted Patent Number D814,042, “Vital Sign Instrument,” covering an integrated system for non-invasive, wireless, and continuous vital sign monitoring. This new patent underscores DMI and rHEALTH’s growing intellectual property portfolio and reflects their ongoing commitment to delivering better care through innovation in portable diagnostics and monitoring technologies.
About rHEALTH
rHEALTH is a digital health solutions company focused on creating integrated technologies that transform healthcare. Its innovations include:
The rHEALTH diagnostic platform, enabling diverse laboratory tests from a single small-volume blood sample for point-of-care use.
The SKYE Sensor, a wireless wearable providing comprehensive, real-time vital sign monitoring.
CHAS, a user-friendly mobile application supporting health management.
For more information, visit www.rhealth.com.
About DNA Medicine Institute
DNA Medicine Institute (DMI) is a biomedical incubator dedicated to advancing patient care, alleviating human suffering, and treating disease through innovation. Supported by NASA, NIH, and the Bill & Melinda Gates Foundation, DMI leverages interdisciplinary science and engineering expertise to tackle challenging biomedical problems.
For more information, visit www.dnamedinstitute.com.
Media Contact
Lillian Li
(617) 913-7630
pr@rhealth.com